Safety of a Single Dose of Moxidectin Compared With Ivermectin in Individuals Living in Onchocerciasis Endemic Areas and in Individuals Living in Onchocerciasis Endemic Areas With High Levels of Lymphatic Filariasis Co-endemicity Receiving Concomitant Albendazole
Clinical trial NCT04311671 · COMPLETED
Trial details
- NCT number
- NCT04311671
- Sponsor
- Medicines Development for Global Health
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-03
- Primary completion
- 2024-09-27
- Enrollment
- 12979
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.